Department of Cardiovascular Surgery, Okayama University Hospital, Okayama, Japan.
Ann Thorac Surg. 2010 Nov;90(5):1615-21. doi: 10.1016/j.athoracsur.2010.07.034.
We devised a miniaturized circuit incorporating a TinyPump in the venous line to amplify the venous return. We compared this system to the conventional blood-primed circuit and investigated whether this circuit could maintain hematocrit levels without blood transfusion and reduce coagulation and inflammatory cascades.
Thirteen 1-week-old piglets (3.7 ± 0.2 kg) were divided into group M (miniaturized circuits with TinyPump-assisted venous drainage without blood, n = 7) and group C (conventional circuits with blood priming, n = 6). Cardiopulmonary bypass (CPB) was performed at 150 to 180 mL·kg(-1)·min(-1) for 2 hours, including 60 minutes of cardioplegic cardiac arrest. Modified ultrafiltration (MUF) was subsequently performed. Data were acquired before CPB and after the end of MUF.
The priming volume including the hemofilter circuit of the main circuit required 152 mL in group M and 300 mL in group C. The mean hematocrit values in group M and group C were not significantly different during CPB (21.5% ± 2.0% versus 23.2% ± 1.3%) or after MUF (30.7% ± 2.1% versus 32.9% ± 4.0%). After MUF, group M had lower thrombin-antithrombin complex levels (16.7 ± 5.0 ng/mL versus 28.4 ± 8.4 ng/mL, p < 0.01) and interleukin-8 levels (2,867 ± 758 pg/mL versus 13,730 ± 5,220 pg/mL, p < 0.01) than group C. The pulmonary vascular resistance index was lower in group M after MUF (4,105 ± 862 dynes·cm(-5)·kg(-1) versus 6,304 ± 1,477 dynes·cm(-5)·kg(-1), p < 0.01). The lung water content was also better in group M (83.7% ± 0.5% versus 84.9% ± 0.5%, p < 0.01).
The minicircuit with TinyPump-assisted venous drainage successfully maintained acceptable hematocrit levels and the cardiopulmonary function in neonatal piglets. Employing this technique may attenuate blood requirements and inflammatory responses, thereby improving the clinical outcomes of neonatal open-heart surgery.
我们设计了一种微型化的回路,在静脉中加入 TinyPump 以放大静脉回流。我们将该系统与传统的血预充回路进行了比较,并研究了该回路是否可以在不输血的情况下维持血细胞比容水平,以及是否可以减少凝血和炎症级联反应。
将 13 头 1 周龄的小猪(3.7±0.2kg)分为 M 组(微型回路+TinyPump 辅助静脉引流,无血,n=7)和 C 组(常规回路+血预充,n=6)。心肺旁路(CPB)在 150-180ml·kg-1·min-1 下进行 2 小时,包括 60 分钟的心脏停搏。随后进行改良超滤(MUF)。CPB 前和 MUF 后采集数据。
M 组主回路加血液滤过器的预充液体积为 152ml,C 组为 300ml。CPB 期间(21.5%±2.0%对 23.2%±1.3%)和 MUF 后(30.7%±2.1%对 32.9%±4.0%),M 组和 C 组的平均血细胞比容值无显著差异。MUF 后,M 组的凝血酶-抗凝血酶复合物水平(16.7±5.0ng/ml 对 28.4±8.4ng/ml,p<0.01)和白细胞介素-8 水平(2867±758pg/ml 对 13730±5220pg/ml,p<0.01)均低于 C 组。MUF 后,M 组肺血管阻力指数较低(4105±862dynes·cm-5·kg-1对 6304±1477dynes·cm-5·kg-1,p<0.01)。M 组肺水含量也较好(83.7%±0.5%对 84.9%±0.5%,p<0.01)。
TinyPump 辅助静脉引流的微型回路成功地维持了新生儿小猪可接受的血细胞比容水平和心肺功能。采用该技术可减少血液需求和炎症反应,从而改善新生儿心脏直视手术的临床结局。